Literature DB >> 11724914

The molecular pathology of CJD: old and new variants.

G S Jackson1, J Collinge.   

Abstract

The study of prion disease has become an area of intense interest since experimental evidence emerged for the transmission of phenotypic variation without the involvement of a nucleic acid component. Additional impetus has come from the widespread concern that exposure to bovine spongiform encephalopathy contaminated material poses a distinct and, conceivably, a severe threat to public health in the UK and other countries. The occurrence of new variant Creutzfeldt-Jakob disease has dramatically highlighted the need for a precise understanding of the molecular basis of prion propagation. The molecular basis of prion strain diversity, previously a major challenge to the "protein only" model, can now be reconciled with propagation of infectious protein topologies. The conformational change known to be central to prion propagation, from a predominantly alpha-helical fold to one predominantly comprising beta-structure, can now be reproduced in vitro, and the ability of beta-PrP to form fibrillar aggregates provides a plausible molecular mechanism for prion propagation. Concomitantly, advances in the fundamental biology of prion disease have done much to reinforce the protein only hypothesis of prion replication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724914      PMCID: PMC1187129     

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  59 in total

1.  Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions.

Authors:  D Shmerling; I Hegyi; M Fischer; T Blättler; S Brandner; J Götz; T Rülicke; E Flechsig; A Cozzio; C von Mering; C Hangartner; A Aguzzi; C Weissmann
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

2.  Scrapie prion protein contains a phosphatidylinositol glycolipid.

Authors:  N Stahl; D R Borchelt; K Hsiao; S B Prusiner
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

3.  NMR solution structure of the human prion protein.

Authors:  R Zahn; A Liu; T Lührs; R Riek; C von Schroetter; F López García; M Billeter; L Calzolai; G Wider; K Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

4.  Scrapie prions aggregate to form amyloid-like birefringent rods.

Authors:  S B Prusiner; M P McKinley; K A Bowman; D C Bolton; P E Bendheim; D F Groth; G G Glenner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

5.  A protease-resistant protein is a structural component of the scrapie prion.

Authors:  M P McKinley; D C Bolton; S B Prusiner
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

6.  Identification of a protein that purifies with the scrapie prion.

Authors:  D C Bolton; M P McKinley; S B Prusiner
Journal:  Science       Date:  1982-12-24       Impact factor: 47.728

7.  Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent.

Authors:  R A Bessen; R F Marsh
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  Pathogenesis of mouse scrapie: evidence for neural spread of infection to the CNS.

Authors:  R H Kimberlin; C A Walker
Journal:  J Gen Virol       Date:  1980-11       Impact factor: 3.891

9.  Prion dementia without characteristic pathology.

Authors:  J Collinge; F Owen; M Poulter; M Leach; T J Crow; M N Rossor; J Hardy; M J Mullan; I Janota; P L Lantos
Journal:  Lancet       Date:  1990-07-07       Impact factor: 79.321

10.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

View more
  10 in total

Review 1.  Epigenetic control of aging.

Authors:  Ursula Muñoz-Najar; John M Sedivy
Journal:  Antioxid Redox Signal       Date:  2010-11-22       Impact factor: 8.401

Review 2.  Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.

Authors:  Vladimir N Uversky; Alexander V Kabanov; Yuri L Lyubchenko
Journal:  J Proteome Res       Date:  2006-10       Impact factor: 4.466

3.  Fibrillization of recombinant bovine prion protein (rec-PrP) in vitro.

Authors:  V B Grigoriev; S L Kalnov; A N Pokidyshev; V V Tsibezov; M V Balandina; R A Gibadulin; O A Verkhovsky; S M Klimenko
Journal:  Dokl Biochem Biophys       Date:  2008 May-Jun       Impact factor: 0.788

Review 4.  Immunization treatment approaches in Alzheimer's and prion diseases.

Authors:  Thomas Wisniewski; Einar M Sigurdsson
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

5.  Molecular dynamics studies of alpha-helix stability in fibril-forming peptides.

Authors:  Erik Nordling; Yvonne Kallberg; Jan Johansson; Bengt Persson
Journal:  J Comput Aided Mol Des       Date:  2007-12-06       Impact factor: 3.686

6.  Removal of the glycosylphosphatidylinositol anchor from PrP(Sc) by cathepsin D does not reduce prion infectivity.

Authors:  Patrick A Lewis; Francesca Properzi; Kanella Prodromidou; Anthony R Clarke; John Collinge; Graham S Jackson
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

7.  NMR structure and CD titration with metal cations of human prion alpha2-helix-related peptides.

Authors:  Luisa Ronga; Pasquale Palladino; Gabriella Saviano; Teodorico Tancredi; Ettore Benedetti; Raffaele Ragone; Filomena Rossi
Journal:  Bioinorg Chem Appl       Date:  2007       Impact factor: 7.778

8.  Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi.

Authors:  Yusuke Ohnishi; Yoshiko Tamura; Mariko Yoshida; Katsushi Tokunaga; Hirohiko Hohjoh
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

Review 9.  Recombinant PrP and Its Contribution to Research on Transmissible Spongiform Encephalopathies.

Authors:  Jorge M Charco; Hasier Eraña; Vanessa Venegas; Sandra García-Martínez; Rafael López-Moreno; Ezequiel González-Miranda; Miguel Ángel Pérez-Castro; Joaquín Castilla
Journal:  Pathogens       Date:  2017-12-14

10.  Putaminal diffusion tensor imaging measures predict disease severity across human prion diseases.

Authors:  Harpreet Hyare; Enrico De Vita; Marie-Claire Porter; Ivor Simpson; Gerard Ridgway; Jessica Lowe; Andrew Thompson; Chris Carswell; Sebastien Ourselin; Marc Modat; Liane Dos Santos Canas; Diana Caine; Zoe Fox; Peter Rudge; John Collinge; Simon Mead; John S Thornton
Journal:  Brain Commun       Date:  2020-04-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.